|drug4256||Vitamin Super B-Complex Wiki||0.58|
|D045169||Severe Acute Respiratory Syndrome NIH||0.04|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
The aim of the COVI-PRONE Trial is to determine if early awake prone positioning in COVID-19 patients with hypoxemic respiratory failure; irrespective of the mode of oxygen delivery; reduces the need for invasive mechanical ventilation.
Description: Medical procedure in which a tube is placed into the windpipe (trachea) through the mouth.Measure: Endotracheal intubation Time: within 30 days of randomization
Description: DeathMeasure: Mortality Time: 60 days
Description: Number of days not receiving mechanical ventilationMeasure: Invasive mechanical ventilation free days Time: 30 Days
Description: Number of days not receiving non-invasive mechanical ventilationMeasure: Non-invasive ventilation free days Time: 30 days
Description: Number of days admitted to ICUMeasure: ICU length of stay Time: 30 Days
Description: Number of days admitted to the hospitalMeasure: Hospital length of stay Time: 30 days
Description: defined as the difference in SpO2: FiO2 ratio. The difference in SpO2: FiO2 ratio.Measure: Change in oxygenation Time: 30 days
Description: Includes any of the following: accidental removal of intravenous access, vomiting, falls from bed, pressure injuries, or cardiac arrest.Measure: Complications from proning, Time: 30 days
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports